Advanced Biomed (ADVB) Equity Ratio (2024 - 2026)

Advanced Biomed has disclosed Equity Ratio across 3 years of filings, most recently posting 0.87 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.87, up 73.6% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.87 (up 73.6% YoY), and the FY2025 annual result was 0.25, down 32.02% from the prior year.
• Equity Ratio came in at 0.87 for Q1 2026 at Advanced Biomed, down from 0.87 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.87 in Q4 2025 to a low of 0.14 in Q4 2024.
• The 3-year median for Equity Ratio is 0.48 (2025), against an average of 0.5.
• Peak annual rise in Equity Ratio reached 535.81% in 2025, while the deepest fall reached 32.02% in 2025.
• Advanced Biomed's Equity Ratio stood at 0.14 in 2024, then surged by 535.81% to 0.87 in 2025, then declined by 1.0% to 0.87 in 2026.
• The last three Equity Ratio figures came in at 0.87 (Q1 2026), 0.87 (Q4 2025), and 0.48 (Q3 2025), per Business Quant data.